• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Market and Potential for Molecular Point of Care 2021

$4,000.00 – $8,000.00

Clear
SKU: 21-014 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Tags: molecular point-of-care market, mPOC Flu, mPOC RSV, mPOC Strep, Near Patient Molecular IVD Market, Respiratory Segment Breakout, Small-Footprint Molecular Point of Care Market Pages: 115
  • Description
  • Table of Contents
  • Latest reports

Description

This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting.

Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of new systems and menu expansion on existing lines is constant. Kalorama Information defines molecular point of care or mPOC as consisting of devices marketed to customers outside the reference lab that run PCR or other DNA and RNA testing on a device with a small footprint. mPOC systems tend to have a result time fast enough for an office visit or bedside consultation. These systems feature cartridges or reduced preparation steps and limited interpretation of test results.

This was a subset of the testing industry still proving its merit to customers early last year, but certainly the COVID-19 pandemic has been an influence on the market, as we suggested in the last report. The ability to deliver rapid PCR results has put them in the right place with the right function at the right time.  This report features a complete update on mPOC and COVID-19. It also discusses other growth areas.

The data in The Market and Potential for Molecular Point of Care 2021 includes information on systems and competitor analysis, as well as data on the size and growth of the market:

  • Current Molecular POC Systems
  • Molecular Point of Care Market: 2020-2025
  • COVID mPOC Market
  • Molecular Point of Care Market Share by Vendor, 2020 ($M, %)
  • Small-Footprint Molecular Point of Care Market, 2020 (%)
  • Geographic Breakout of the Molecular Point of Care Market, 2020 (N. America, Europe, APAC, RoW)
  • Segment Breakout of Molecular Point of Care Market, 2020 (Respiratory vs. Other)
  • Breakout of Molecular Point of Care Market, 2020 (%; Respiratory, Other)
  • Respiratory Segment Breakout, 2020 (Flu, RSV, Strep, Other)
  • Breakout of mPOC Respiratory, 2020 (%; Flu, Strep, RSV, Other)
  • Near Patient Molecular IVD Market: 2020-2025
  • Near Patient Molecular Market Share by Vendor, 2020
  • Company Profiles

Many trends are covered in the report, including menu expansion, disease statistics, the COVID-19 crisis, immunoassay competition and enhancement of those competitive POC systems, emerging markets, new journal studies about the efficacy of mPOC and other trends.

Companies profiled include:

  • Abbott Laboratories
  • Aidian Oy
  • Akonni Biosystems
  • binx health, inc.
  • Biocartis NV
  • bioMérieux SA
  • Cepheid
  • Credo Bioscience
  • Curetis NV
  • DiaSorin S.p.A
  • GenMark Diagnostics
  • Greiner Bio-One GmbH
  • Meridian Bioscience, Inc.
  • Mesa Biotech, Inc.
  • QIAGEN NV
  • QuantuMDx Group
  • Quidel Corporation
  • Roche
  • Sekisui Diagnostics LLC
  • T2 Biosystems

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

WHERE IS MOLECULAR POINT OF CARE IN 2021?
MOLECULAR POINT OF CARE MARKET ANALYSIS

    • Table 1-1: Molecular Point of Care Market: 2019-2024
  • Figure 1-1: mPOC Market by Disease Indication, 2019 (%; Respiratory, Other)
  • Market Observations
  • “Near-Patient” Molecular Systems Market
    • Table 1-2: Near Patient Molecular Systems Market: 2019-2024

CURRENT TRENDS
COVID-19 and mPOC
MOLECULAR POINT-OF-CARE DIAGNOSTICS DEFINED

  • USAGE OF MOLECULAR POINT OF CARE
  • LEADING MPOC PLATFORMS
    • Table 1-3: Market-Available Molecular POC Diagnostic Platforms
  • TRENDS

SCOPE AND METHODOLOGY

CHAPTER TWO: MOLECULAR POINT-OF-CARE MARKET DEVELOPMENT AND TRENDS

  • ADVANTAGES AND DISADVANTAGES OF MOLECULAR POINT OF CARE
    • Table 2-1: Disadvantages of Molecular Point of Care, by Setting
  • JUSTIFICATION: THE SENSITIVITY/SPECIFICITY ARGUMENT
  • NEW SYSTEMS AND MENU EXPANSION
    • Table 2-2: Recent Menu Expansions for Hospital and POC Molecular Platforms (Vendor, Platform, Menu Addition, Time to Results, CLIA-waiver, US/EU Availability)

INVESTMENT IN MPOC SYSTEMS

  • CHINA AS A POC MARKET
  • COMMON TESTS AND ANALYTES IN POC DIAGNOSTICS
  • COMPONENT TECHNOLOGIES OF MOLECULAR POINT-OF-CARE DIAGNOSTICS
    • Microfluidics
    • qPCR
    • Microarrays
    • Isothermal Amplification
    • Test Automation
    • Primers and Probes
    • Detection
    • Next-Generation Sequencing
  • MOLECULAR DIAGNOSTICS
    • Real-Time PCR (qPCR)
    • Isothermal Amplification Methods
    • Line Probe Assays
    • Next-Generation Sequencing
  • APPLICATIONS AND POTENTIAL APPLICATIONS FOR MOLECULAR POINT-OF-CARE
    • COVID-19
    • Major Testing Applications for Molecular POC Diagnostics
    • Influenza
    • Hospital-Acquired Infections (HAIs)
    • Strep A
    • Respiratory Syncytial Virus (RSV)

EMERGING APPLICATIONS

  • Other Respiratory Infections
  • Group B Streptococcus
  • STDs
  • Tuberculosis
  • Malaria
  • Other Tropical and Neglected Diseases
  • Cancer
  • EUROPEAN DEVICE REGULATIONS NEARING

CHAPTER THREE: MARKET ANALYSIS

  • MOLECULAR POINT OF CARE MARKET ANALYSIS
    • Table 3-1: Molecular Point of Care Market: 2019-2024
    • Table 3-2: Molecular Point of Care Market Share by Vendor, 2019 ($M, %)
    • Figure 3-1: Small-Footprint Molecular Point of Care Market, 2019 (%)
    • Table 3-3: Geographic Breakout of the Molecular Point of Care Market, 2019 (N. America, Europe, APAC, RoW)
    • Table 3-4: Segment Breakout of Molecular Point of Care Market, 2019 (Respiratory vs. Other)
    • Figure 3-2: Breakout of Molecular Point of Care Market, 2019 (%; Respiratory, Other)
  • Respiratory Molecular Point of Care Segmentation
    • Table 3-5: Respiratory Segment Breakout, 2019 (Flu, RSV, Strep, Other)
    • Figure 3-3: Breakout of mPOC Respiratory, 2019 (%; Flu, Strep, RSV, Other)

“NEAR PATIENT MOLECULAR” MARKET

    • Table 3-6: Near Patient Molecular IVD Market: 2019-2024
  • Market Share Near Patient
    • Table 3-7: Near Patient Molecular Market Share by Vendor, 2019

CHAPTER FOUR: COMPANY PROFILES

  • ABBOTT LABORATORIES
  • AIDIAN OY
  • AKONNI BIOSYSTEMS
  • BINX HEALTH, INC.
  • BIOCARTIS NV
  • BIOMÉRIEUX SA
  • CEPHEID
    • Molecular Healthcare-Acquired Infection (HAI) Testing
    • Molecular Sexual Health and Women’s Health Testing
    • Molecular Critical Infectious Disease Testing
    • Molecular Oncology/Genetics Testing
  • CREDO BIOSCIENCE
  • CURETIS NV
  • DIASORIN S.P.A
  • GENMARK DIAGNOSTICS
  • GREINER BIO-ONE GMBH
  • MERIDIAN BIOSCIENCE, INC.
  • MESA BIOTECH, INC.
  • QIAGEN NV
  • QUANTUMDX GROUP
  • QUIDEL CORPORATION
  • ROCHE
  • SEKISUI DIAGNOSTICS LLC
  • T2 BIOSYSTEMS
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic...COVID-19 Testing Update 2021: Molecular and Antigen Markets, Procedures, Mutations,...
Scroll to top